Related Experiment Videos
Elevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease.
Akira Andoh1, Tomoyuki Tsujikawa, Kazunori Hata
1Department of Internal Medicine, Shiga University of Medical Science, Seta Tukinowa, Otsu, Japan.
The American Journal of Gastroenterology
|September 1, 2005
Summary
Platelet-derived microparticles (PDMPs) are elevated in active inflammatory bowel disease (IBD). These levels correlate with disease activity and decrease upon remission, suggesting platelets play a role in IBD.
Area of Science:
- Immunology
- Gastroenterology
- Hematology
Background:
- Platelet-derived microparticles (PDMPs) are bioactive molecules implicated in hemostasis and inflammation.
- Understanding platelet function alterations is crucial for inflammatory bowel disease (IBD) research.
Purpose of the Study:
- To investigate circulating PDMP levels in patients with ulcerative colitis (UC) and Crohn's disease (CD).
- To evaluate the correlation between PDMP levels and IBD disease activity.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure PDMP and soluble P-selectin (sP-selectin) levels.
- Study included 25 healthy controls, 44 UC patients, and 43 CD patients.
Main Results:
- PDMP levels were significantly higher in active UC and CD patients compared to healthy controls.
- PDMP levels correlated significantly with clinical activity indexes in both UC and CD.
- Elevated PDMP levels decreased significantly after achieving remission and correlated with sP-selectin levels.
Conclusions:
- Circulating PDMPs are elevated in active IBD patients.
- Platelets may contribute to the pathogenesis of inflammatory bowel disease.